Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/09/2000 | EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens |
08/09/2000 | EP1025434A1 A multichannel microscale system for high throughput preparative separation with comprehensive collection and analysis |
08/09/2000 | EP1025265A1 Methods for detecting contamination in molecular diagnostics using pcr |
08/09/2000 | EP1025262A1 Screening for novel bioactivities |
08/09/2000 | EP1025261A1 Compositions and methods for determining predisposition to insulin dependent diabetes mellitus |
08/09/2000 | EP1025253A1 Positive-negative selection for homologous recombination |
08/09/2000 | EP1025252A1 Efficient construction of gene targeting vectors |
08/09/2000 | EP1025251A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors |
08/09/2000 | EP1025250A2 Modification of the tocopherol content of transgenic plants |
08/09/2000 | EP1025249A1 Novel seed specific promoters based on plant genes |
08/09/2000 | EP1025248A1 Reduction of chlorophyll content in oil plant seeds |
08/09/2000 | EP1025247A1 In planta method for the production of transgenic plants |
08/09/2000 | EP1025246A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins |
08/09/2000 | EP1025245A2 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
08/09/2000 | EP1025244A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
08/09/2000 | EP1025243A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS |
08/09/2000 | EP1025242A1 A method of inhibiting an immune response to a recombinant vector |
08/09/2000 | EP1025241A2 Multiply-substituted protease variants |
08/09/2000 | EP1025240A2 Multiply-substituted protease variants with altered net charge for use in detergents |
08/09/2000 | EP1025239A2 Multiply-substituted protease variants |
08/09/2000 | EP1025238A2 Death associated kinase containing ankyrin repeats (dakar) |
08/09/2000 | EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods |
08/09/2000 | EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods |
08/09/2000 | EP1025235A1 Expression system |
08/09/2000 | EP1025234A1 Binary viral expression system in plants |
08/09/2000 | EP1025233A2 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems |
08/09/2000 | EP1025232A1 A novel mitogenic cyclin and uses thereof |
08/09/2000 | EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
08/09/2000 | EP1025230A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE |
08/09/2000 | EP1025229A1 Chemokines with amino-terminal modifications |
08/09/2000 | EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
08/09/2000 | EP1025227A2 Human toll homologues |
08/09/2000 | EP1025226A1 Dna encoding a human proton-gated ion channel and uses thereof |
08/09/2000 | EP1025225A1 P-40/annexin i and related proteins and their role in multidrug resistance |
08/09/2000 | EP1025224A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses |
08/09/2000 | EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
08/09/2000 | EP1025222A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function |
08/09/2000 | EP1025221A2 ErbB-4 TARGETED RIBOZYMES |
08/09/2000 | EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF |
08/09/2000 | EP1025219A2 Antisense oligonucleotide sequences as inhibitors of microorganisms |
08/09/2000 | EP1025218A1 Method to screen phage display libraries with different ligands |
08/09/2000 | EP1025217A1 Recombinational cloning using nucleic acids having recombination sites |
08/09/2000 | EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
08/09/2000 | EP1025215A2 Plant phosphatases |
08/09/2000 | EP1025213A1 Epoxide hydrolase |
08/09/2000 | EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
08/09/2000 | EP1025211A2 Hyaluronan synthase gene and uses thereof |
08/09/2000 | EP1025210A2 Plant branched-chain amino acid biosynthetic enzymes |
08/09/2000 | EP1025208A2 A packaging cell line producing siv-pseudotyped mlv |
08/09/2000 | EP1025207A1 Suspension packing cell lines for retrovirus vectors |
08/09/2000 | EP1025206A1 Cell lines useful for (in vitro) assay for identification of carcinogens |
08/09/2000 | EP1025205A2 (in vitro) differentiation of vascular smooth muscle cells, methods and reagents related thereto |
08/09/2000 | EP1025204A1 Methods and materials for the growth of primate-derived primordial stem cells |
08/09/2000 | EP1025203A1 Impaired brca2 function in cells and non-human transgenic animals |
08/09/2000 | EP1025194A1 Bleaching compositions comprising multiply-substituted protease variants |
08/09/2000 | EP1025129A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
08/09/2000 | EP1025124A1 Low-toxicity human interferon-alpha analogues |
08/09/2000 | EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity |
08/09/2000 | EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR |
08/09/2000 | EP1025113A1 Improved process for performing polynucleotide separations |
08/09/2000 | EP1024836A1 Method of delivering genes to antigen presenting cells of the skin |
08/09/2000 | EP1024828A1 NOVEL pheS (BETA) |
08/09/2000 | EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
08/09/2000 | EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
08/09/2000 | EP1024822A1 Cd8 as an inhibitor of the cellular immune system |
08/09/2000 | EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
08/09/2000 | EP1024809A1 Use of immunomodulating agents |
08/09/2000 | EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
08/09/2000 | EP0868119A4 Conditionally male-fertile plants and methods and compositions for restoring the fertility thereof |
08/09/2000 | EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor |
08/09/2000 | EP0663010B1 Methods for increasing secretion of overexpressed proteins |
08/09/2000 | EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
08/09/2000 | EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
08/09/2000 | EP0568645B1 Mixed specificity fusion proteins |
08/09/2000 | EP0556171B1 Growth hormone antagonists |
08/09/2000 | EP0533846B1 The ciliary neurotrophic factor receptor |
08/09/2000 | CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same |
08/09/2000 | CN1262689A Isolated dendritic cell membrane protein genes |
08/09/2000 | CN1262687A Eukaryotic and retroviral antisense initiator elements |
08/09/2000 | CN1262328A Expression function of vascular bundle for specifically expressing different sigments of promotor profilin 2 |
08/09/2000 | CN1262326A Transgenosis plant containing vergence soy-bean isodynamic calcium modulated protein gene for resisting multiple diseases |
08/09/2000 | CN1262323A High-pressure gas gene gun |
08/09/2000 | CN1262032A Animal ceratin transgenic cotton fibre and its gene engineering method |
08/09/2000 | CN1055314C Cloning and over expression of glucose-6-phosphate dehydrogenase fro leuconostoc dextranicus |
08/09/2000 | CN1055313C Recombinative plasmid for high-efficient expressing HBsAg in cell of mammal |
08/09/2000 | CN1055312C Method for preparation of human interleukin-6 and its products |
08/09/2000 | CA2327264A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide |
08/08/2000 | US6100456 Lepidopteran insect resistant transgenic potato plants |
08/08/2000 | US6100453 Genetically engineering plants against infection; transforming pear cultivars with a gene which encodes for a lytic protein, recovering hybrid pears which lack sensitivity to plant disease |
08/08/2000 | US6100451 Nucleic acid sequences associated with transcriptional control in plants; for the development of disease resistance plants |
08/08/2000 | US6100450 Nucleotide sequences associated with heterologous gene expression in plants |
08/08/2000 | US6100449 Nucleotide sequences which code protein which prevents or reduces fungal infection |
08/08/2000 | US6100448 Increasing expression of transgenes in plant cells using insulator elements |
08/08/2000 | US6100447 Method of barley transformation |
08/08/2000 | US6100446 Plant cell transformed with nucleotide sequences which code a degratory enzymatic protein; for pollution control |
08/08/2000 | US6100445 Hybrid rodent with homogeneity for cytokine mutation; for prevention of apoptosis; antiproliferative agents |
08/08/2000 | US6100444 Nucleotide sequences coding prostate gland protein; for the treatment of prostate cancer |
08/08/2000 | US6100443 Universal donor cells |
08/08/2000 | US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals |
08/08/2000 | US6100389 Nucleotide sequences coding protein: for stem cell mobilization, myloid and neuronal cell protection; for the treatment and prevention of tumors and parasitic infection; wound healing agents; antitumor agents |